相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New composite endpoint in early diffuse cutaneous systemic sclerosis: revisiting the provisional American College of Rheumatology Composite Response Index in Systemic Sclerosis
Dinesh Khanna et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes
Alain Lescoat et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2021)
Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database
Camelia Frantz et al.
AUTOIMMUNITY REVIEWS (2020)
OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies
Maarten Boers et al.
JOURNAL OF RHEUMATOLOGY (2019)
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
Oliver Distler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
The nosology of systemic sclerosis: how lessons from the past offer new challenges in reframing an idiopathic rheumatological disorder
Alain Lescoat et al.
LANCET RHEUMATOLOGY (2019)
Synovial involvement assessed by power Doppler ultra-sonography in systemic sclerosis: results of a cross-sectional study
Alain Lescoat et al.
RHEUMATOLOGY (2018)
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Andrea C. Tricco et al.
ANNALS OF INTERNAL MEDICINE (2018)
Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach
Zachary Munn et al.
BMC MEDICAL RESEARCH METHODOLOGY (2018)
Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis A Randomized, Placebo-Controlled, Phase II Study
Christopher P. Denton et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study
Eric Hachulla et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Impaired quality of life in systemic sclerosis and patient perception of the disease: A large international survey
Camelia Frantz et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)
The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis
Dinesh Khanna et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Nailfold Videocapillaroscopic Features and Other Clinical Risk Factors for Digital Ulcers in Systemic Sclerosis: A Multicenter, Prospective Cohort Study
Maurizio Cutolo et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
Donald P. Tashkin et al.
LANCET RESPIRATORY MEDICINE (2016)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
Larissa Shamseer et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
Larissa Shamseer et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews
Abigail M. Methley et al.
BMC HEALTH SERVICES RESEARCH (2014)
Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0
Maarten Boers et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2014)
How to Choose Core Outcome Measurement Sets for Clinical Trials: OMERACT 11 Approves Filter 2.0
Maarten Boers et al.
JOURNAL OF RHEUMATOLOGY (2014)
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group
J. Avouac et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
The Future of Measuring Patient-Reported Outcomes in Rheumatology
Dinesh Khanna et al.
ARTHRITIS CARE & RESEARCH (2011)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Scoping studies: advancing the methodology
Danielle Levac et al.
IMPLEMENTATION SCIENCE (2010)
Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis
S. I. Nihtyanova et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Development of a provisional core set of response measures for clinical trials of systemic sclerosis
D. Khanna et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis
P. J. Clements et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon -: A multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril
A. E. Gliddon et al.
ARTHRITIS AND RHEUMATISM (2007)
Health values of patients with systemic sclerosis
Dinesh Khanna et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Digital ulcers in systemic sclerosis - Prevention by treatment with bosentan, an oral endothelin receptor antagonist
JH Korn et al.
ARTHRITIS AND RHEUMATISM (2004)
分享论文
